Biomineralization Mechanisms in Breast Cancer Pathophysiology

Biomineralisation in breast cancer denotes the regulated deposition of mineral phases within malignant tissue, most notably through the formation of microcalcifications. These microscale calcium phosphate deposits arise via cell-mediated processes involving extracellular matrix remodelling, vesicular transport of mineral precursors and enzyme-driven modulation of local ion concentrations. Hydroxyapatite emerges as the dominant phase, often interspersed with magnesium-rich whitlockite or transient precursors such as octacalcium phosphate. The bioactivity of tumour cells, including expression of osteopontin and activation of signalling pathways such as PI3K-Akt, influences nucleation sites and crystal maturation. Microcalcifications not only serve as diagnostic markers on mammography but also reflect the biochemical and biophysical tumour microenvironment, linking acidity, protein expression and mineral composition. Recent advances illuminate how specific ionic substitutions and crystallographic parameters correlate with lesion aggressiveness, offering novel prognostic biomarkers. A deeper understanding of these biomineralisation mechanisms promises to enhance early detection, refine risk stratification and inspire targeted interventions aimed at altering the mineralisation process to impede tumour progression.

Research from Nature Portfolio

Studies over the past two years have detailed the crystallographic and chemical signatures of microcalcifications in ductal carcinoma in situ (DCIS). Analysis of calcification maturity and element ratios including sodium to calcium distinguished cases with subsequent invasive recurrence, yielding a preliminary predictive model of disease progression. Investigations into cell culture models revealed that breast cancer cells can acquire placental alkaline phosphatase activity under an osteogenic stimulus, with the PI3K-Akt pathway driving enzyme recruitment and subsequent mineral deposition. Foundational work further quantified elemental composition across benign and malignant specimens, demonstrating distinct magnesium and sodium substitutions in the hydroxyapatite lattice that correlate with lesion pathology and may inform non-invasive diagnostics.

Biomineralization Mechanisms in Breast Cancer Pathophysiology publication trend

The graph below shows the total number of articles in biomineralization mechanisms in breast cancer pathophysiology across all publications each year (not limited to Nature Index journals).

Technical terms

Biomineralisation: The biologically controlled process by which cells deposit inorganic minerals within tissues.

Microcalcification: Microscopic calcium phosphate deposits observed in breast tissue, detectable by imaging.

Hydroxyapatite: The primary crystalline form of calcium phosphate found in bone and pathological calcifications.

Whitlockite: A magnesium-containing calcium phosphate phase occurring alongside hydroxyapatite in calcifications.

Osteopontin: A phosphorylated glycoprotein that modulates mineral nucleation and crystal growth in the extracellular matrix.

PI3K-Akt signalling pathway: A cellular cascade implicated in growth and survival that regulates enzymes driving mineral deposition.

References

1. Microcalcification crystallography as a potential marker of DCIS recurrence. Scientific Reports (2023).
2. Elemental vs. phase composition of breast calcifications. Scientific Reports (2017).
3. Osteogenic cocktail induces calcifications in human breast cancer cell line via placental alkaline phosphatase expression. Scientific Reports (2020).
4. A multi-modal exploration of heterogeneous physico–chemical properties of DCIS breast microcalcifications. Analyst (2022).
5. Microcalcifications in breast cancer tissue studied by X-ray absorption, emission, scattering and diffraction. Journal of Applied Crystallography (2025).